C136H139Cl6N39 — CID 157396926
5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclobutylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclohexylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(2-cyclopentylethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclopropylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[2-(diethylamino)ethyl]-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[(3-methylimidazolidin-1-yl)methyl]-6-phenylpyrazine-2,3-diamine (PubChem CID 157396926) has the molecular formula C136H139Cl6N39 and a molecular weight of 2532.60 g/mol. Its IUPAC name is 5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclobutylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclohexylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(2-cyclopentylethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclopropylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[2-(diethylamino)ethyl]-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[(3-methylimidazolidin-1-yl)methyl]-6-phenylpyrazine-2,3-diamine.
| Compound Name | 5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclobutylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclohexylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(2-cyclopentylethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclopropylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[2-(diethylamino)ethyl]-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[(3-methylimidazolidin-1-yl)methyl]-6-phenylpyrazine-2,3-diamine |
|---|---|
| PubChem CID | 157396926 |
| Molecular Formula | C136H139Cl6N39 |
| Molecular Weight | 2532.60 g/mol |
| Exact Mass | 2528.02 |
| IUPAC Name | 5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclobutylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclohexylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(2-cyclopentylethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-(cyclopropylmethyl)-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[2-(diethylamino)ethyl]-6-phenylpyrazine-2,3-diamine;5-(7-chloro-1H-indazol-5-yl)-3-N-[(3-methylimidazolidin-1-yl)methyl]-6-phenylpyrazine-2,3-diamine |
| SMILES | CCN(CC)CCNc1nc(-c2cc(Cl)c3[nH]ncc3c2)c(-c2ccccc2)nc1N.CN1CCN(CNc2nc(-c3cc(Cl)c4[nH]ncc4c3)c(-c3ccccc3)nc2N)C1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)nc1NCC1CC1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)nc1NCC1CCC1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)nc1NCC1CCCCC1.Nc1nc(-c2ccccc2)c(-c2cc(Cl)c3[nH]ncc3c2)nc1NCCC1CCCC1 |
| InChI | InChI=1S/2C24H25ClN6.C23H26ClN7.C22H23ClN8.C22H21ClN6.C21H19ClN6/c25-19-12-17(11-18-14-28-31-20(18)19)22-21(16-9-5-2-6-10-16)29-23(26)24(30-22)27-13-15-7-3-1-4-8-15;25-19-13-17(12-18-14-28-31-20(18)19)22-21(16-8-2-1-3-9-16)29-23(26)24(30-22)27-11-10-15-6-4-5-7-15;1-3-31(4-2)11-10-26-23-22(25)28-20(15-8-6-5-7-9-15)21(29-23)16-12-17-14-27-30-19(17)18(24)13-16;1-30-7-8-31(13-30)12-25-22-21(24)27-19(14-5-3-2-4-6-14)20(28-22)15-9-16-11-26-29-18(16)17(23)10-15;23-17-10-15(9-16-12-26-29-18(16)17)20-19(14-7-2-1-3-8-14)27-21(24)22(28-20)25-11-13-5-4-6-13;22-16-9-14(8-15-11-25-28-17(15)16)19-18(13-4-2-1-3-5-13)26-20(23)21(27-19)24-10-12-6-7-12/h2,5-6,9-12,14-15H,1,3-4,7-8,13H2,(H2,26,29)(H,27,30)(H,28,31);1-3,8-9,12-15H,4-7,10-11H2,(H2,26,29)(H,27,30)(H,28,31);5-9,12-14H,3-4,10-11H2,1-2H3,(H2,25,28)(H,26,29)(H,27,30);2-6,9-11H,7-8,12-13H2,1H3,(H2,24,27)(H,25,28)(H,26,29);1-3,7-10,12-13H,4-6,11H2,(H2,24,27)(H,25,28)(H,26,29);1-5,8-9,11-12H,6-7,10H2,(H2,23,26)(H,24,27)(H,25,28) |
| InChIKey | BMRIRWGZVJNHFN-UHFFFAOYSA-N |
| XLogP | 29.88 |
| TPSA | 564.78 Ų |
| H-Bond Donors | 18 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 181 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2532.60 |
| LogP ≤ 5 | 29.88 |
| H-Bond Donors ≤ 5 | 18 |
| H-Bond Acceptors ≤ 10 | 33 |